Opportunistic infections in paediatric inflammatory bowel disease patients

摘要

Inflammatory bowel disease (IBD) is a chronic relapsing and remitting disease that is increasing in incidence throughout the Western world.1 Although multiple questions regarding its aetiology remain, immunosuppressive therapy is used as the mainstream treatment in both adults and children.2 Concerns have been raised regarding their safety and potential side effects on a short-term and long-term basis. Several databases have been initiated to evaluate this effect.